SCHEMBL4777017

SCHEMBL4777017

Cc1nc2c(Br)cc(C(=O)N(C)C)cc2n1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.34
RAB9A P51151 6/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 1/20 0.33
PABPC1 P11940 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HDAC1 Q13547 1/20 0.33
MAPT P10636 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
POLB P06746 1/20 0.32
EGFR P00533 1/20 0.32
ABL1 P00519 1/20 0.32
BRD4 O60885 1/20 0.31
ACSS2 Q9NR19 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3555267 0.84 ALDH1A1 (0.34) NPC1RAB9AALDH1A1KDM4EHTT
SCHEMBL4592596 0.83 MAP4K1 (0.36) NPC1RAB9AALDH1A1KDM4EHTT
SCHEMBL21820452 0.80 LMNA (0.46) NPC1RAB9AALDH1A1KDM4EKMT2A
SCHEMBL29833073 0.80 LMNA (0.46) NPC1RAB9AALDH1A1KDM4EKMT2A
SCHEMBL4633246 0.79 LMNA (0.42) NPC1RAB9AALDH1A1KDM4EHTT
SCHEMBL31497731 0.76 BRD4 (0.47) HDAC1MAPTBRD4
SCHEMBL4633318 0.74 MAP4K1 (0.34) ALDH1A1
SCHEMBL5901177 0.73 KDM4E (0.30) ALDH1A1KDM4EHTTGAAPABPC1
SCHEMBL17875680 0.73 EGFR (0.46) NPC1RAB9AALDH1A1KDM4EHTT
SCHEMBL4662880 0.72 BRD4 (0.50) NPC1RAB9AALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008017466-A1 PHARMACEUTICALLY ACTIVE TETRAHYDROISOQUINOLINE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES NYCOMED GMBH (DE) 2008-02-14 WO disclosed